A detailed history of Jane Street Group, LLC transactions in Seres Therapeutics, Inc. stock. As of the latest transaction made, Jane Street Group, LLC holds 86,438 shares of MCRB stock, worth $62,235. This represents 0.0% of its overall portfolio holdings.

Number of Shares
86,438
Previous 290,287 70.22%
Holding current value
$62,235
Previous $406,000 83.74%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$0.75 - $1.56 $152,886 - $318,004
-203,849 Reduced 70.22%
86,438 $66,000
Q4 2023

Feb 14, 2024

BUY
$0.93 - $2.15 $242,624 - $560,907
260,887 Added 887.37%
290,287 $406,000
Q3 2023

Nov 14, 2023

SELL
$2.33 - $5.07 $117,508 - $255,695
-50,433 Reduced 63.17%
29,400 $69,000
Q2 2023

Aug 14, 2023

BUY
$4.67 - $6.55 $187,981 - $263,657
40,253 Added 101.7%
79,833 $382,000
Q1 2023

May 15, 2023

SELL
$4.95 - $6.09 $25,784 - $31,722
-5,209 Reduced 11.63%
39,580 $224,000
Q4 2022

Feb 14, 2023

BUY
$5.09 - $9.05 $227,976 - $405,340
44,789 New
44,789 $250,000
Q2 2022

Aug 16, 2022

SELL
$2.7 - $7.62 $51,732 - $145,999
-19,160 Closed
0 $0
Q1 2022

May 17, 2022

SELL
$6.3 - $8.84 $863,270 - $1.21 Million
-137,027 Reduced 87.73%
19,160 $137,000
Q4 2021

Feb 15, 2022

BUY
$6.02 - $11.43 $450,494 - $855,341
74,833 Added 91.98%
156,187 $1.3 Million
Q3 2021

Nov 16, 2021

SELL
$5.46 - $22.6 $69,101 - $286,025
-12,656 Reduced 13.46%
81,354 $567,000
Q2 2021

Aug 16, 2021

BUY
$18.46 - $24.36 $350,518 - $462,547
18,988 Added 25.31%
94,010 $2.24 Million
Q1 2021

May 18, 2021

SELL
$17.66 - $28.92 $109,721 - $179,679
-6,213 Reduced 7.65%
75,022 $1.55 Million
Q4 2020

Feb 17, 2021

BUY
$23.25 - $37.73 $1.04 Million - $1.68 Million
44,600 Added 121.74%
81,235 $1.99 Million
Q3 2020

Nov 17, 2020

BUY
$3.74 - $28.74 $83,431 - $641,131
22,308 Added 155.71%
36,635 $1.04 Million
Q2 2020

Aug 17, 2020

BUY
$3.04 - $6.2 $7,919 - $16,151
2,605 Added 22.22%
14,327 $68,000
Q1 2020

May 15, 2020

SELL
$2.64 - $3.82 $120,661 - $174,593
-45,705 Reduced 79.59%
11,722 $42,000
Q4 2019

Feb 14, 2020

SELL
$2.99 - $4.42 $104,413 - $154,350
-34,921 Reduced 37.81%
57,427 $198,000
Q3 2019

Nov 14, 2019

SELL
$2.29 - $4.16 $51,092 - $92,813
-22,311 Reduced 19.46%
92,348 $370,000
Q2 2019

Aug 15, 2019

BUY
$2.28 - $7.35 $261,422 - $842,743
114,659 New
114,659 $369,000

Others Institutions Holding MCRB

About Seres Therapeutics, Inc.


  • Ticker MCRB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 124,072,000
  • Market Cap $89.3M
  • Description
  • Seres Therapeutics, Inc., a microbiome therapeutics platform company, engages in developing bacterial consortia that are designed to functionally interact with host cells and tissues to treat disease. The company's lead product candidate is the SER-109, an oral microbiome therapeutic candidate that has completed Phase III clinical trial for the ...
More about MCRB
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.